Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07287111Not ApplicableCompleted

Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound

Role: lead

NCT06622967Not ApplicableActive Not Recruiting

KNUCH CadAI-B-1(KCB-1)

Role: collaborator

NCT06352684Active Not Recruiting

Multi-Reader Multi-Case, Retrospective Study to Evaluate Effectiveness of CadAI-B for Breast

Role: lead

All 3 trials loaded